Table 2.
Experimental conditions and outcomes
| Model | Disease state | Diet/treatment | ANA | Renal disease | Atherosclerosis. |
|---|---|---|---|---|---|
| MRL-lpr – ‘mild’ 1 | Early | NC/Rosi. | ↓ | ↓ | n/a |
| gld.apoE−/−1 | Early | NC/Rosi. | ↓ | ↓ | ↓ |
| MRL-lpr – ‘mild’ | Early | NC/Pio. | ↓ | ↓ | n/a |
| MRL-lpr – ‘mild’ | Established | NC/Rosi. | No change | No change | n/a |
| MRL-lpr – ‘severe’ | Severe | NC/Rosi. | No change | No change | n/a |
| gld.apoE−/− | Established | NC/Rosi. | No change | No change | ↓ |
| gld.apoE−/− | Severe | WD/Rosi. | No change | ↓ | ↓ |
ANA, anti-nuclear antibodies; NC, Normal chow; WD, Western diet.
8.